- Home
- AUTL vs MAX Comparison
AUTL vs MAX Comparison
Compare AUTL & MAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- MAX
- Stock Information
- Founded
- AUTL 2014
- MAX 2014
- Country
- AUTL United Kingdom
- MAX United States
- Employees
- AUTL N/A
- MAX N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- MAX Industrial Machinery/Components
- Sector
- AUTL Health Care
- MAX Industrials
- Exchange
- AUTL Nasdaq
- MAX Nasdaq
- Market Cap
- AUTL 625.4M
- MAX 551.1M
- IPO Year
- AUTL 2018
- MAX 2020
- Fundamental
- Price
- AUTL $1.31
- MAX $13.02
- Analyst Decision
- AUTL Strong Buy
- MAX Strong Buy
- Analyst Count
- AUTL 5
- MAX 6
- Target Price
- AUTL $9.12
- MAX $18.25
- AVG Volume (30 Days)
- AUTL 4.2M
- MAX 637.5K
- Earning Date
- AUTL 11-11-2025
- MAX 10-29-2025
- Dividend Yield
- AUTL N/A
- MAX N/A
- EPS Growth
- AUTL N/A
- MAX N/A
- EPS
- AUTL N/A
- MAX N/A
- Revenue
- AUTL $29,934,000.00
- MAX $1,075,712,000.00
- Revenue This Year
- AUTL $634.25
- MAX $28.71
- Revenue Next Year
- AUTL $93.16
- MAX $9.61
- P/E Ratio
- AUTL N/A
- MAX N/A
- Revenue Growth
- AUTL 185.17
- MAX 116.58
- 52 Week Low
- AUTL $1.11
- MAX $7.33
- 52 Week High
- AUTL $5.00
- MAX $20.91
- Technical
- Relative Strength Index (RSI)
- AUTL 46.08
- MAX 68.95
- Support Level
- AUTL N/A
- MAX $12.56
- Resistance Level
- AUTL $1.46
- MAX $13.28
- Average True Range (ATR)
- AUTL 0.08
- MAX 0.55
- MACD
- AUTL -0.04
- MAX 0.17
- Stochastic Oscillator
- AUTL 79.88
- MAX 86.63
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About MAX MediaAlpha Inc.
MediaAlpha Inc provides a platform that facilitates insurance carriers and distributors target and acquire customers. The company's technology platform brings insurance carriers and consumers together through a real-time, transparent, and results-driven ecosystem. It acts as a customer acquisition channel in the areas of property & casualty insurance, health insurance, and life insurance. It operates in the United States and generates revenue by earning a fee for each consumer referral sold on its platform.